3/26
07:30 am
sngx
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
Medium
Report
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
3/25
01:52 am
sngx
Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting [Yahoo! Finance]
Low
Report
Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting [Yahoo! Finance]
3/23
08:00 am
sngx
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026 [Yahoo! Finance]
Low
Report
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026 [Yahoo! Finance]
3/23
07:30 am
sngx
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Low
Report
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
3/19
08:10 pm
sngx
Soligenix (SNGX) Highlights HyBryte Clinical Data in Peer-Reviewed Journal Publication [Yahoo! Finance]
Neutral
Report
Soligenix (SNGX) Highlights HyBryte Clinical Data in Peer-Reviewed Journal Publication [Yahoo! Finance]
3/19
08:00 am
sngx
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
Medium
Report
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
3/19
07:30 am
sngx
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
Medium
Report
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
3/10
07:42 am
sngx
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency [Yahoo! Finance]
Low
Report
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency [Yahoo! Finance]
3/10
07:30 am
sngx
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
Low
Report
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
2/26
07:45 am
sngx
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease [Yahoo! Finance]
Low
Report
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease [Yahoo! Finance]
2/26
07:30 am
sngx
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
High
Report
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
2/24
07:54 am
sngx
Soligenix to Present at BIO Investment & Growth Summit [Yahoo! Finance]
Medium
Report
Soligenix to Present at BIO Investment & Growth Summit [Yahoo! Finance]
2/24
07:30 am
sngx
Soligenix to Present at BIO Investment & Growth Summit
Medium
Report
Soligenix to Present at BIO Investment & Growth Summit
2/12
07:30 am
sngx
Soligenix Details Recent Progress and Upcoming Milestones
Low
Report
Soligenix Details Recent Progress and Upcoming Milestones
1/24
05:10 am
sngx
Soligenix (NASDAQ:SNGX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Soligenix (NASDAQ:SNGX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.